Parkinson’s disease as a result of aging

Cites (396)

Items 201–396 of 396

1. Locus coeruleus cell loss in the aging human brain: A non‐random process
   K. Manaye, D. McIntire, David M. A. Mann, D. German · 1995 · The Journal of comparative neurology
2. Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase
   Rona Ruth Ramsay, Matthew J. Krueger, Stephen K. Youngster · 1991 · Journal of Neurochemistry
3. Protective effects and mechanisms of sirtuins in the nervous system
   Zhang, Feng, Wang, Suping, Gan, Li, Vosler, Peter S., Gao, Yanqin, Zigmond, Michael J., Chen, Jun · 2011 · Progress in Neurobiology
4. Glutathione and Parkinson's disease: Is this the elephant in the room?
   Gail Duffy Zeevalk, Roozbeh Razmpour, Laura P. Bernard · 2008 · Biomedicine & Pharmacotherapy
5. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function
   Fayet, Guillemette, Jansson, Monica, Sternberg, Damien, Moslemi, Ali-Reza, Blondy, Patricia, Lombès, Anne, Fardeau, Michel, Oldfors, Anders · 2002 · Neuromuscular Disorders
6. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling
   Fabiola Olivieri, Raffaella Lazzarini, Rina Recchioni, Fiorella Marcheselli, Maria Rita Rippo, Silvia Nuzzo, Maria Cristina Albertini, Laura Graciotti, Lucia Babini, Serena Mariotti et al. · 2012 · AGE
7. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
   Carlos Barcia, Angel Sánchez-Bahíllo, Emiliano Fernández‐Villalba, Víctor Bautista‐Hernández, M. Poza, A Fernández-Barreiro, Étienne C. Hirsch, María Trinidad Herrero · 2004 · Glia
8. Remarkable longevity and stress resistance of nematode PI3K‐null mutants
   Srinivas Ayyadevara, Ramani Alla, John J. Thaden, Robert J. Shmookler Reis · 2007 · Aging Cell
9. Ultra-Deep Sequencing of Mouse Mitochondrial DNA: Mutational Patterns and Their Origins
   Adam Ameur, James Bruce Stewart, Christoph Freyer, Erik Hagström, Max Ingman, Nils‐Göran Larsson, Ulf B Gyllensten · 2011 · PLoS Genetics
10. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults
    Mitsugi Okawara, Hiroshi Katsuki, Emi Kurimoto, Haruki Shibata, Toshiaki Kume, Akinori Akaike · 2006 · Biochemical Pharmacology
11. Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum
    John W. Haycock, Laurence Edward Becker, Lee Cyn Ang, Yoshiaki Furukawa, Oleh Hornykiewicz, Stephen J. Kish · 2003 · Journal of Neurochemistry
12. Oxidative Stress and MicroRNAs in Vascular Diseases
    Alessandra Magenta, Simona Greco, Carlo Gaetano, Fabio Martelli · 2013 · International Journal of Molecular Sciences
13. Mitochondria as a central sensor for axonal degenerative stimuli
    Felipe A. Court, Michael P. Coleman · 2012 · Trends in Neurosciences
14. Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
    Steven W. Coon, Azadeh T. Stark, Edward L. Peterson, Aime M Gloi, Gene X. Kortsha, Joel G. Pounds, David R. Chettle, Jay M. Gorell · 2006 · Environmental Health Perspectives
15. Clinical Phenotype of Families with Longevity
    Gil Atzmon, Clyde B. Schechter, William Greiner, Deborah E. Davidson, Gad Rennert, Nir Barzilai · 2004 · Journal of the American Geriatrics Society
16. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease
    Isidró Ferrer, Anna Martinez, Rosa E. Blanco, Esther Dalfó, Margarita Carmona · 2010 · Journal of Neural Transmission
17. Mitochondrial involvement in Parkinson's disease
    Michael Orth · 2002 · Neurochemistry International
18. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism
    C.B. Lücking, N. Abbas, Alexandra Dürr, Vincenzo Bonifati, Anne Marie Bonnet, T. de Broucker, Giuseppe De Michele, Nicholas William Wood, Yves Agid, Alexis Brice · 1998 · The Lancet
19. Age-related Changes in Locus Ceruleus on Neuromelanin Magnetic Resonance Imaging at 3 Tesla
    Eri Shibata, Makoto Sasaki, Koujiro Tohyama, Yoshiyuki Kanbara, Kotaro Otsuka, Shigeru Ehara, Akio SAKAI · 2006 · Magnetic Resonance in Medical Sciences
20. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
    Jianfei Chao, Man-Shan Yu, Janice Yuen Shan Ho, Mingfu Wang, Raymond Chuen‐Chung Chang · 2008 · Free Radical Biology and Medicine
21. Iron metabolism in Parkinsonian syndromes
    Daniela Berg, Helmine Hochstrasser · 2006 · Movement Disorders
22. A brief history of levodopa
    Oleh Hornykiewicz · 2010 · Journal of Neurology
23. Morphometry of the human substantia nigra in ageing and Parkinson’s disease
    Gay L. Rudow, Richard O’Brien, Alena V. Savonenko, Susan M. Resnick, Alan B. Zonderman, Olga Pletniková, Laura Marsh, Ted M. Dawson, Barbara J. Crain, Mark J. West et al. · 2008 · Acta Neuropathologica
24. The mitochondrial theory of aging: Insight from transgenic and knockout mouse models
    Youngmok Charles Jang, Holly Van Remmen · 2009 · Experimental Gerontology
25. The comparative biology of neuromelanin and lipofuscin in the human brain
    Kay L. Double, Vadim N. Dedov, Heidi Fedorow, Emma Kettle, Glenda Margaret Halliday, Brett Garner, Ulf T. Brunk · 2008 · Cellular and Molecular Life Sciences
26. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Walter Pirker, Susanne Asenbaum, M Hauk, Susanne Kandlhofer, Johannes T. Tauscher, Matthäus Willeit, Alexander Neumeister, Nicole Praschak-Rieder, Peter Angelberger, Th. Brücke · 2000 · PubMed
27. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
    Wenxue Li, Christian Lesuisse, Yanqun Xu, Juan Carlos Troncoso, Donald L. Price, Michael K. Lee · 2004 · Journal of Neuroscience
28. Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease
    C. Venkateshappa, Gangadharappa Harish, Rajeswara Babu Mythri, Anita Mahadevan, M. M. Srinivas Bharath, S.K. Shankar · 2011 · Neurochemical Research
29. Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions
    Kenneth G. Lloyd, Oleh Hornykiewicz · 1970 · Science
30. Interleukin-6 in the aging brain
    Jonathan P. Godbout, Rodney W. Johnson · 2003 · Journal of Neuroimmunology
31. Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain
    Frederick P. Bellinger, Miyoko T. Bellinger, Lucia A. Seale, Andrea S. Takemoto, Arjun V. Raman, Takanori Miki, Amy Manning-Bog, Marla J. Berry, Lon R. White, G Ross · 2011 · Molecular Neurodegeneration
32. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain
    James R. Goss, Caleb E. Finch, David Gene Morgan · 1991 · Neurobiology of Aging
33. Astrocytes aged <i>in vitro</i> show a decreased neuroprotective capacity
    Pertusa, M., García‐Matas, S., Rodríguez‐Farré, E., Sanfeliu, C., Cristòfol, R. · 2007 · Journal of Neurochemistry
34. MicroRNAs in Parkinson's disease
    M. Maral Mouradian · 2012 · Neurobiology of Disease
35. Proteome analysis of human substantia nigra in Parkinson's disease
    Cornelius Johannes Werner, Roland Heyny‐von Haußen, Gerhard Mall, Sabine Wolf · 2008 · Proteome Science
36. Thalamic changes in Parkinson's disease
    Glenda Margaret Halliday · 2009 · Parkinsonism & Related Disorders
37. Critical Evaluation of the Free Radical Theory of Aging
    Byung Pal Yu, Ryung Yang · 1996 · Annals of the New York Academy of Sciences
38. Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?
    Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R.‐M., Campisi, J., Andersen, J. K. · 2013 · Journal of Internal Medicine
39. Mitochondrial involvement in Alzheimer’s disease
    Eduardo Bonilla, Kurenai Tanji, Michio Hirano, Tuan Vu, Salvatore DiMauro, Eric A. Schon · 1999 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
40. Persistent organochlorine pesticides in serum and risk of Parkinson disease
    Marc G. Weisskopf, Paul Knekt, Éilis J. O’Reilly, Jukka Lyytinen, Antti Reunanen, Francine Laden, Larisa Altshul, Alberto Ascherio · 2010 · Neurology
41. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long term losses of dopamine neurons in offspring a potential new model of parkinson s disease
    Paul M. Carvey · 2003 · Frontiers in bioscience
42. Mitochondrial biogenesis in the axons of vertebrate peripheral neurons
    Mandana Amiri, Peter J. Hollenbeck · 2008 · Developmental Neurobiology
43. MicroRNAs in Parkinson's disease
    Maged M. Harraz, Ted M. Dawson, Valina Lynn Dawson · 2011 · Journal of Chemical Neuroanatomy
44. Monoamine Metabolism in Human Brain
    Donald S. Robinson · 1977 · Archives of General Psychiatry
45. Oxidative Stress and Parkinson's Diseasea
    A Owen, Anthony H.V. Schapira, Peter G. Jenner, C. DAVID MARSDEN · 1996 · Annals of the New York Academy of Sciences
46. Microglial degeneration in the aging brain - bad news for neurons?
    Streit, Wolfgang, J. · 2008 · Frontiers in Bioscience
47. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts
    Raffaella Faraonio, Paolo Salerno, Fabiana Passaro, Carla Sedia, Annalisa Iaccio, Roberto Bellelli, Tito Claudio Nappi, Marika Comegna, S Romano, Giuliana Salvatore et al. · 2011 · Cell Death and Differentiation
48. Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy
    C. R. Cabello, Jens Jakob Thune, Henning Pakkenberg, Bente Pakkenberg · 2002 · Neuropathology and Applied Neurobiology
49. The Role of Oxidative Stress in the Aging Process
    Bárbara Fonseca de Oliveira, José Augusto Nogueira‐Machado, Mı́riam Martins Chaves · 2010 · The Scientific World JOURNAL
50. A Morphometric Study of Age-Dependent Changes in Mitochondrial Populations of Mouse Liver and Heart
    George H. Herbener · 1976 · Journal of Gerontology
51. Spermidine and spermine are enriched in whole blood of nona/centenarians
    Pucciarelli, Stefania, Moreschini, Benedetta, Micozzi, Daniela, De Fronzo, Giusi S., Carpi, Francesco M., Polzonetti, Valeria, Vincenzetti, Silvia, Mignini, Fiorenzo, Napolioni, Valerio · 2012 · Rejuvenation Research
52. Diverse cellular and molecular modes of axon degeneration
    Lukas Jakob Neukomm, Marc R. Freeman · 2014 · Trends in Cell Biology
53. Glutathione release from cultured brain cells: Multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells
    Johannes Hirrlinger, Jörg Bernhard Schulz, Ralf Dringen · 2002 · Journal of Neuroscience Research
54. Dopamine receptor subtype imbalance in schizophrenia
    Ellen J. Hess, H. Stefan Bracha, Joel E. Kleinman, Ian Creese · 1987 · Life Sciences
55. Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain
    Na Li, David J. Bates, Jin An, Derek A. Terry, Eugenia Wang · 2009 · Neurobiology of Aging
56. Increase in Dopamine Turnover Occurs Early in Parkinson's Disease: Evidence from a New Modeling Approach to PET 18 F-Fluorodopa Data
    Vesna Sossi, Raúl de la Fuente‐Fernández, James E. Holden · 2002 · Journal of Cerebral Blood Flow & Metabolism
57. Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases
    Akihiko Nunomura, Paula Isabel Moreira, Hyoung‐gon Lee, X. Zhu, Rudy J. Castellani, Mark A. Smith, George L. Perry · 2007 · CNS & Neurological Disorders - Drug Targets
58. Emerging restorative treatments for Parkinson's disease
    Tomas Deierborg, Denis Soulet, Laurent Roybon, Vanessa Jane Hall, Patrik Brundin · 2008 · Progress in Neurobiology
59. Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy
    Hsiao-Chun Cheng, Sang Ryong Kim, Tinmarla Frances Oo, Tatyana Kareva, Olga Yarygina, Margarita Rzhetskaya, Chuansong Wang, Matthew J. During, Zsolt Tallóczy, Keiji Tanaka et al. · 2011 · Journal of Neuroscience
60. Increases of glial fibrillary acidic protein in the aging female mouse brain
    Steven G. Kohama, James R. Goss, Caleb E. Finch, Thomas H. McNeill · 1995 · Neurobiology of Aging
61. Spatiotemporal Changes to the Subventricular Zone Stem Cell Pool through Aging
    Brett A. Shook, David H. Manz, John Jeffrey Peters, Sang‐Wook Kang, Joanne C. Conover · 2012 · Journal of Neuroscience
62. Genome-environment interactions that modulate aging: powerful targets for drug discovery
    de Magalhães, João Pedro, Wuttke, Daniel, Wood, Shona H., Plank, Michael, Vora, Chintan · 2012 · Pharmacological Reviews
63. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system
    Mann, David M.A. · 1983 · Mechanisms of Ageing and Development
64. Mitochondrial production of pro-oxidants and cellular senescence
    Rajindar S. Sohal, Ulf T. Brunk · 1992 · Mutation Research/DNAging
65. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys
    Rodney J. Moore, Sharon L. Vinsant, Michael A. Nader, Linda J. Porrino, David P. Friedman · 1998 · Synapse
66. Sex differences in behavioral despair: Relationships between behavioral despair and open field activity
    Simeona J. Alonso, Miguel Angel Castellano, Daruez Afonso, Manuel Rodrı́guez · 1991 · Physiology & Behavior
67. Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing
    Ma, Röytt, Collan, Rinne · 1999 · Neuropathology and Applied Neurobiology
68. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C
    Gerardo A. Morfini, Gustavo F. Pigino, K. Opalach, Yafell Serulle, Jorge E. Moreira, Mutsuyuki Sugimori, Rodolfó R. Llinás, Scott T. Brady · 2007 · Proceedings of the National Academy of Sciences
69. Biphasic and Region-Specific MAO-B Response to Aging in Normal Human Brain
    Josep Saura, Noemí Andrés, C Andrade, Júlia Ojuel, K Eriksson, Nicole Mahy · 1997 · Neurobiology of Aging
70. Mitochondrial DNA analysis: polymorphisms and pathogenicity
    Patrick Francis Chinnery, Neil Howell, Richard M. Andrews, Douglass M. Turnbull · 1999 · Journal of Medical Genetics
71. Kleemeier Award Lecture: Are There Genes for Aging?
    Richard A. Miller · 1999 · The Journals of Gerontology Series A
72. Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
    Kay L. Double, Stefanie Reyes, Eryn L. Werry, Glenda Margaret Halliday · 2010 · Progress in Neurobiology
73. The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I
    Irene Litvan, Glenda Margaret Halliday, Mark Hallett, Christopher G. Goetz, Walter A. Rocca, Charles J. Duyckaerts, Yoav Ben‐Shlomo, Dennis W. Dickson, Anthony Edward Lang, Marie‐Françoise Chesselet et al. · 2007 · Journal of Neuropathology & Experimental Neurology
74. Mitophagy in neurodegeneration and aging
    Konstantinos Palikaras, Nektarios Tavernarakis · 2012 · Frontiers in Genetics
75. Aging of the nigrostriatal system in the squirrel monkey
    Alison L. McCormack, Donato A. Di Monte, Kioumars Delfani, Ian Irwin, Louis E. DeLanney, J. William Langston, A. M. Janson · 2004 · The Journal of Comparative Neurology
76. The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study
    Kerry Graeme Baker, I. T�rk, Jean‐Pierre Hornung, Paul Halasz · 1989 · Experimental Brain Research
77. Genetics of Parkinson's disease and biochemical studies of implicated gene products
    Peter T. Lansbury, Alexis Brice · 2002 · Current Opinion in Genetics & Development
78. Effects of age on dopamine transporters in healthy humans.
    P. David Mozley, Paul D. Acton, Elizabeth D. Barraclough, Karl Plößl, Ruben C. Gur, Abass A. Alavi, Anil Mathur, Janet R. Saffer, Hank F. Kung · 1999 · PubMed
79. Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
    Kangyong Liu, Nan Shi, Yinyi Sun, Ting Zhang, Xiaojiang Sun · 2012 · Neurochemical Research
80. Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease
    Manuel Rodrı́guez, Pedro Barroso‐Chinea, Patricio Abdala, Jose Angel Obeso, Tomás González‐Hernández · 2001 · Experimental Neurology
81. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies
    Mercè Pallàs, Javier G. Pizarro, Javier Cuesta, Natàlia Crespo‐Biel, Daniel Alvira, Marta Tajes, Marc Yeste‐Velasco, Jaume Folch, Anna Maria Canudas, Francesc Xavier Sureda et al. · 2008 · Neuroscience
82. A STUDY OF SELECTED CATECHOLAMINE METABOLIZING ENZYMES: A COMPARISON OF DEPRESSIVE SUICIDES AND ALCOHOLIC SUICIDES WITH CONTROLS1
    S. S. Grote, Sylvia G. Moses, Eli Robins, Richard W. Hudgens, Adele B. Croninger · 1974 · Journal of Neurochemistry
83. Histological changes of the dopaminergic nigrostriatal system in aging
    Amy K. Stark, Bente Pakkenberg · 2004 · Cell and Tissue Research
84. LongevityMap: a database of human genetic variants associated with longevity
    Arie Budovsky, Thomas Craig, Jingwei Wang, Robi Tăcutu, Attila Csordás, Joana Lourenço, Vadim E. Fraifeld, João Pedro de Magalhães · 2013 · Trends in Genetics
85. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management.
    P M Kidd · 2000 · PubMed
86. Stress‐Induced Premature Senescence: Essence of Life, Evolution, Stress, and Aging
    Olivier Toussaint, PATRICK DUMONT, Jean‐François Dierick, Thierry G. Pascal, Christophe C. Frippiat, Florence Debacq‐Chainiaux, Francis E. Sluse, François Eliaers, José Remacle · 2000 · Annals of the New York Academy of Sciences
87. Neurogenesis in the aging brain
    Kunlin Jin · 2008 · Clinical Interventions in Aging
88. The impact of glial activation in the aging brain.
    Aileen M. Lynch, Kevin J Murphy, Brian F. Deighan, Julie-Ann O’Reilly, Yurii K. Gun’ko, Thelma R. Cowley, Rodrigo E. González-Reyes, Marina A. Lynch · 2010 · Europe PMC (PubMed Central)
89. Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness
    Oleh Hornykiewicz · 2008 · Neurodegenerative Diseases
90. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys
    Greg A. Gerhardt, Wayne A. Cass, Yi Ai, Zhiming Zhang, Don Marshall Gash · 2001 · Journal of Neurochemistry
91. Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector
    Natsumi Hayakawa, Hiroyuki Kato, Tsutomu Araki · 2007 · Mechanisms of Ageing and Development
92. Locus ceruleus morphometry in aging and schizophrenia
    James B. Lohr, Dilip V. Jeste · 1988 · Acta Psychiatrica Scandinavica
93. Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury‐induced cytokine response after excitotoxic damage
    Óscar Campuzano, Maria del Mar Castillo-Ruiz, Laia Acarín, Bernardo Castellano, Berta González · 2009 · Journal of Neuroscience Research
94. The co‐occurrence of mt DNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific
    Nicola Raule, Federica Sevini, Shengting Li, Annalaura Barbieri, Federica Tallaro, Laura Lomartire, Dario Vianello, Alberto Montesanto, Jukka S. Moilanen, Vladislav V Bezrukov et al. · 2013 · Aging Cell
95. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
    Karlijn J. Doorn, Paul John Lucassen, H. W. G. M. Boddeke, Marloes Prins, Henk W. Berendse, Benjamin Drukarch, Anne‐Marie van Dam · 2012 · Progress in Neurobiology
96. Mitochondrial function, fibre types and ageing: new insights from human muscle in vivo
    Kevin E. Conley, Catherine E. Amara, Sharon A. Jubrias, David Joseph Marcinek · 2006 · Experimental Physiology
97. Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.
    E Bertrand, Waldemar Lechowicz, Grazyna Maria Szpak, Jerzy Dymecki · 1997 · PubMed
98. Behavioral lateralization in rats: prenatal stress effects on sex differences
    Josefina Alonso, Miguel Angel Castellano, Manuel Rodrı́guez · 1991 · Brain Research
99. Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability
    Christian M. Müller, Rob A. I. de Vos, Claude‐Alain Maurage, Dietmar Rudolf Thal, Markus Tolnay, Heiko Braak · 2005 · Journal of Neuropathology & Experimental Neurology
100. Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons
     Daniel Alvira, Marc Yeste‐Velasco, Jaume Folch, Ester Verdaguer, Anna Maria Canudas, Mercè Pallàs, Antoni Camins · 2007 · Neuroscience
101. AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE.
     Joanne C. Conover, Brett A. Shook · 2011 · Europe PMC (PubMed Central)
102. The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons
     Amy Katherine Reeve, Martin Meagher, Nicola Lax, Eve M. Simcox, Philippa D. Hepplewhite, Evelyn Jaros, Douglass M. Turnbull · 2013 · Journal of Neuroscience
103. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse
     Jonathan Gilley, Anjan Seereeram, Kunié Ando, Suzanne I.S. Mosely, Simon Andrews, Martin Kerschensteiner, Thomas Misgeld, Jean‐Pierre Brion, Brian H. Anderton, Diane P. Hanger et al. · 2011 · Neurobiology of Aging
104. Relation of aging with oxidative protein damage parameters in the rat skeletal muscle
     Ufuk Çakatay, Ayşegül Telci, Refik Kayalı, Fatma Tekeli, Tülay Akçay, Ahmet Sıvas · 2003 · Clinical Biochemistry
105. Selective autophagy in the maintenance of cellular homeostasis in aging organisms
     Vanessa M. Hubbard, Rut Valdor, Fernando Macián, Ana María Cuervo · 2011 · Biogerontology
106. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice
     Masato Asanuma, Hiroshi Hirata, Jean Lud Cadet · 1998 · Neuroscience
107. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
     Alberto Albanese, Enza Maria Valente, Luigi Michele Romito, Emanuele Bellacchio, Antonio Emanuele Elia, Bruno Dallapiccola · 2005 · Neurology
108. Monoamine re-uptake sites in the human brain evaluatedin vivoby means of11C-nomifensine and positron emission tomography: the effects of age and Parkinson's disease
     Joakim Tedroff, Sten‐Magnus Aquilonius, P. Hartvig, Hans Lundqvist, Antony D. Gee, J. Uhlin, Bengt Långström · 1988 · Acta Neurologica Scandinavica
109. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
     Étienne C. Hirsch, Ann M. Graybiel, Yves Agid · 1989 · Acta Neurologica Scandinavica
110. Mortality, oxidative stress and tau accumulation during ageing in parkin null mice
     José Antonio Rodríguez‐Navarro, Marı́a José Casarejos, Jaime Menéndez, Rosa Maria Solano, Izaskun Rodal, Ana Gómez, Justo Garcı́a de Yébenes, María A. Mena · 2007 · Journal of Neurochemistry
111. Aging‐related changes in astrocytes in the rat retina: imbalance between cell proliferation and cell death reduces astrocyte availability
     Mansour, Hussein, Chamberlain, Coral G., Weible II, Michael W., Hughes, Suzanne, Chu, Yi, Chan‐Ling, Tailoi · 2008 · Aging Cell
112. The ageing epigenome: Damaged beyond repair?
     David A. Sinclair, Philipp Oberdoerffer · 2009 · Ageing Research Reviews
113. Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease
     J. Eric Ahlskog · 2004 · Movement Disorders
114. A Morphometric Study of the Density of Mitochondrial Cristae in Heart and Liver of Aging Mice
     E. L. Tate, George H. Herbener · 1976 · Journal of Gerontology
115. Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging
     David Gene Morgan, Jan O. Marcusson, Per Nyberg · 1987 · Neurobiology of Aging
116. Age‐related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: Relevance to selective neuronal vulnerability
     Nicholas M. Kanaan, Jeffrey H. Kordower, Timothy J. Collier · 2007 · The Journal of Comparative Neurology
117. Somatic mitochondrial DNA mutations in single neurons and glia
     Ippolita Cantuti‐Castelvetri, Michael T. S. Lin, Kangni Zheng, Christine E. Keller-McGandy, Rebecca A. Betensky, Donald R. Johns, M. Flint Beal, David G. Standaert, David K. Simon · 2004 · Neurobiology of Aging
118. The mitochondrial genome in aging and senescence
     Lauri, Andrea, Pompilio, Giulio, Capogrossi, Maurizio C. · 2014 · Ageing Research Reviews
119. There is no such thing as aging
     Richard Peto, Richard Doll · 1997 · BMJ
120. Oxidative stress and Parkinson's disease
     Peter G. Jenner · 2007 · Handbook of clinical neurology
121. Age-related neuronal loss in the rat brain starts at the end of adolescence
     Morterá, Priscilla, Herculano-Houzel, Suzana · 2012 · Frontiers in Neuroanatomy
122. The Effect of Age on Mitochondrial Ultrastructure
     Patricia D. Wilson, L. M. Franks · 2009 · Gerontologia
123. Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease
     Manuel Rodrı́guez, Patricio Abdala, Pedro Barroso‐Chinea, Jose Angel Obeso, Tomás González‐Hernández · 2001 · Behavioural Brain Research
124. Parkinson's disease and family history
     A Sellbach, Richard S. Boyle, Peter A. Silburn, George D. Mellick · 2006 · Parkinsonism & Related Disorders
125. Comparison of two-dimensional electrophoresis patterns of heat shock protein Hsp27 species in normal and cardiomyopathic hearts
     Christian Scheler, Xinping Li, Johann Salnikow, Michael James Dunn, Peter Roman Jungblut · 1999 · Electrophoresis
126. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene
     Shoichi Sasaki, Hitoshi Warita, Koji Abe, Makoto Iwata · 2005 · Acta Neuropathologica
127. Ageing and neurotoxins as causative factors in idiopathic parkinson's disease—a critical analysis of the neurochemical evidence
     Oleh Hornykiewicz · 1989 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
128. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity
     Lir‐Wan Fan, Lu‐Tai Tien, Baoying Zheng, Yi Pang, Rick C.S. Lin, Kimberly L. Simpson, Tangeng Ma, Philip G. Rhodes, Zhengwei Cai · 2010 · Brain Behavior and Immunity
129. Molecular and cellular gerontology Serpiano, Switzerland, September 18–22, 1999
     Ch. Brack, Gordon J. Lithgow, Heinz Osiewacz, Olivier Toussaint · 2000 · The EMBO Journal
130. Electrophysiological and Morphological Evidence for a GABAergic Nigrostriatal Pathway
     Manuel Rodrı́guez, Tomás González‐Hernández · 1999 · Journal of Neuroscience
131. Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
     Sarika Srivastava, Marcia C. Haigis · 2011 · Current Pharmaceutical Design
132. On the immortality of the germ line: Genetic and biochemical mechanisms. A review
     Жорес Александрович Медведев · 1981 · Mechanisms of Ageing and Development
133. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons
     Tomás González‐Hernández, Pedro Barroso‐Chinea, Abraham Acevedo‐Arozena, EDUARDO C. SALIDO, Manuel Rodrı́guez · 2001 · European Journal of Neuroscience
134. Immunocytochemical Quantification of Tyrosine Hydroxylase at a Cellular Level in the Mesencephalon of Control Subjects and Patients with Parkinson's and Alzheimer's Disease
     Anne Kästner, Étienne C. Hirsch, María Trinidad Herrero, France Javoy-Agid, Yves Agid · 1993 · Journal of Neurochemistry
135. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease
     Satoshi Orimo, Toshiki Uchihara, T. Kanazawa, Yasuhiro Itoh, Koichi Wakabayashi, Akiyoshi Kakita, Hitoshi Takahashi · 2011 · Neuropathology and Applied Neurobiology
136. Primary vs. secondary recurrent pregnancy loss – epidemiological characteristics, etiology, and next pregnancy outcome
     Efrat Shapira, Ronit Ratzon, Ilana Shoham‐Vardi · 2012 · Journal of Perinatal Medicine
137. Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease
     Rafal M. Smigrodzki, Shaharyar M. Khan · 2005 · Rejuvenation Research
138. The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging
     Daniel Edgar, Aleksandra Trifunović · 2009 · Aging
139. ‘Senescence‐associated’ β‐galactosidase activity in the upper gastrointestinal tract
     James J. Going, Robert C. Stuart, Martin Downie, Aileen J. Fletcher‐Monaghan, W. Nicol Keith · 2002 · The Journal of Pathology
140. 6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structures
     Jorge R. Barrio, Siyuan Huang, William P. Melega · 1990 · Journal of Neuroscience Research
141. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron–glia crosstalk
     Ana Saavedra, Graça Baltazar, Paulo Rodrigues‐Santos, Caetana Monteiro Carvalho, Emı́lia P. Duarte · 2006 · Neurobiology of Disease
142. Is aging programed?
     Steven N. Austad · 2004 · Aging Cell
143. Evidence for specific phases in the development of human neuromelanin
     Glenda Margaret Halliday, Heidi Fedorow, C. H. Rickert, M. Gerlach, Peter Franz Riederer, Kay L. Double · 2006 · Journal of Neural Transmission
144. Aging of the rat mesostriatal system: Differences between the nigrostriatal and the mesolimbic compartments
     Ignacio Cruz‐Muros, Domingo Afonso‐Oramas, Pedro M. Abreu, Pedro Barroso‐Chinea, Manuel Rodrı́guez, M. Carmen González, Tomás González‐Hernández · 2006 · Experimental Neurology
145. Programmed ageing: the theory of maximal metabolic scope
     Roland Prinzinger · 2005 · EMBO Reports
146. Parkinson's disease, pesticides and individual vulnerability
     Moreno Paolini, Andrea Sapone, Frank J. Gonzalez · 2004 · Trends in Pharmacological Sciences
147. Sir-2.1 modulates ‘calorie-restriction-mediated’ prevention of neurodegeneration in Caenorhabditis elegans: Implications for Parkinson’s disease
     Pooja Jadiya, Manavi Chatterjee, Shreesh Raj Sammi, Supinder Kaur, Gautam Palit, Aamir Nazir · 2011 · Biochemical and Biophysical Research Communications
148. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
     Ayaka Numao, Keisuke Suzuki, Masayuki Miyamoto · 2013 · Parkinsonism & Related Disorders
149. Molecular mechanisms of ageing and related diseases
     Junping Liu · 2014 · Clinical and Experimental Pharmacology and Physiology
150. Age‐related changes in dopamine transporters and accumulation of 3‐nitrotyrosine in rhesus monkey midbrain dopamine neurons: Relevance in selective neuronal vulnerability to degeneration
     Nicholas M. Kanaan, Jeffrey H. Kordower, Timothy J. Collier · 2008 · European Journal of Neuroscience
151. Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons
     Mong-Lin Yang, Linda Hasadsri, Wendy S. Woods, Julia M. George · 2010 · Molecular Neurodegeneration
152. Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
     Lir‐Wan Fan, Lu‐Tai Tien, Rick C.S. Lin, Kimberly L. Simpson, Philip G. Rhodes, Zhengwei Cai · 2011 · Neurobiology of Disease
153. Mitochondrial DNA content contributes to healthy aging in Chinese: a study from nonagenarians and centenarians
     Yonghan He, Xiang Lu, Huan Wu, Wangwei Cai, Li-Qin Yang, Liang‐You Xu, Hongpeng Sun, Qing‐Peng Kong · 2014 · Neurobiology of Aging
154. Increased dopamine synthesis in aging substantia nigra neurons
     Carol E. Greenwood, W. G. Tatton, Nadine A. Seniuk · 1991 · Neurobiology of Aging
155. Senescence-accelerated Mice (SAMs) as a Model for Brain Aging and Immunosenescence.
     Atsuyoshi Shimada, Sanae Hasegawa‐Ishii · 2011 · Europe PMC (PubMed Central)
156. The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II
     Irene Litvan, Marie‐Françoise Chesselet, Thomas Gasser, Donato A. Di Monte, Davis Parker, Theo Hagg, John Hardy, Peter G. Jenner, Richard H. Myers, Donald D. Price et al. · 2007 · Journal of Neuropathology & Experimental Neurology
157. Aging risk factors and Parkinson's disease: contrasting roles of common dietary constituents
     Alan R. Hipkiss · 2013 · Neurobiology of Aging
158. Neonatal Systemic Exposure to Lipopolysaccharide Enhances Susceptibility of Nigrostriatal Dopaminergic Neurons to Rotenone Neurotoxicity in Later Life
     Zhengwei Cai, Lir‐Wan Fan, Asuka Kaizaki, Lu‐Tai Tien, Tangeng Ma, Yi Pang, Shuying Lin, Rick C.S. Lin, Kimberly L. Simpson · 2013 · Developmental Neuroscience
159. The role of non-synaptic extracellular glutamate
     Manuel Rodrı́guez, Magdalena Sabaté, Clara Rodriguez‐Sabate, Ingrid Moráles · 2012 · Brain Research Bulletin
160. The biological significance of meiosis.
     R. Holliday · 1984 · PubMed
161. Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice
     Ying Dai, Tomas Kiselak, Joanne Clark, Elizabeth L. Clore, Kangni Zheng, Allen A. Cheng, Gregory C. Kujoth, Tomas A. Prolla, Eleftheria Maratos–Flier, David K. Simon · 2013 · Mitochondrion
162. Parkinson-Linked Genes and Toxins That Affect Neuronal Cell Death Through the Bcl-2 Family
     Douglas W. Ethell, Qingyan Fei · 2008 · Antioxidants and Redox Signaling
163. The Yin-Yang of Sirtuins
     Andrew G. Dillin, Jeffery W. Kelly · 2007 · Science
164. The Role of Microglial Cellular Senescence in the Aging and Alzheimer Diseased Brain
     Flanary, Barry · 2005 · Rejuvenation Research
165. Autoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self β-Synuclein
     Felix Mor, Francisco Javier Quintana, Avishai Mimran, Irun R. Cohen · 2003 · The Journal of Immunology
166. Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism
     P. Ibáñez, Giuseppe De Michele, Vincenzo Bonifati et al. · 2003 · Neurology
167. Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease
     Ronald F. Pfeiffer · 2010 · Movement Disorders
168. A Novel Look at Astrocytes
     Andreas F. Mack, Hartwig Wolburg · 2012 · The Neuroscientist
169. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake
     Diego Pablo de la Hera, Gerardo Raul Corradi, Hugo Pedro Adamo, Felicitas de Tezanos Pinto · 2012 · Biochemical Journal
170. The glia doctrine: Addressing the role of glial cells in healthy brain ageing
     Erlend Arnulf Nagelhus, Mahmood Reza Amiry-Moghaddam, Linda Hildegard Bergersen, Jan Gunnar Bjaalie, Jens Eriksson, Vidar Gundersen, Trygve Brauns Leergaard, Jens Preben Morth, Jon Storm‐Mathisen, Reidun Torp et al. · 2013 · Mechanisms of Ageing and Development
171. Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect
     Kenji Ishibashi, Keiichi Oda, Kiichi Ishiwata, Kenji Ishii · 2014 · Journal of the Neurological Sciences
172. Astrocytes as neural stem cells in the adult brain.
     Óscar González-Pérez, Alfredo Quiñones‐Hinojosa · 2012 · PubMed
173. Astrocyte-neuron interactions
     Eduardo Elias Benarroch · 2009 · Neurology
174. PPAR-α Expression Inversely Correlates with Inflammatory Cytokines IL-1β and TNF-α in Aging Rats
     David S. Gélinas, JoAnne McLaurin · 2005 · Neurochemical Research
175. A review of why and how we age: A defense of multifactorial aging
     Charles B. Olson · 1987 · Mechanisms of Ageing and Development
176. iPSCs, aging and age-related diseases
     Ken‐ichi Isobe, Zhao Cheng, Naomi Nishio, Suganya Thanasegaran, Yuriko Tanaka, Sachiko Ito · 2014 · New Biotechnology
177. Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging
     Ignacio Cruz‐Muros, Domingo Afonso‐Oramas, Pedro M. Abreu, Manuel Rodrı́guez, M. Carmen González, Tomás González‐Hernández · 2007 · Neurobiology of Aging
178. Age-related changes of neuronal counts in the human pedunculopontine nucleus
     Gerhard N. Ransmayr, Baptiste A. Faucheux, C Nowakowski, Nathalie Kubis, S. Federspiel, Walter Anton Kaufmann, Dominique Hénin, J J Hauw, Yves Agid, Étienne C. Hirsch · 2000 · Neuroscience Letters
179. Fetal brain serotonin synthesis and catabolism is under control by mother intake of tryptophan
     R. Arévalo, Daruez Afonso, Rafael Castro, Manuel Rodrı́guez · 1991 · Life Sciences
180. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease
     Ingrid Moráles, Magdalena Sabaté, Manuel Rodrı́guez · 2013 · European Journal of Neuroscience
181. Self‐induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity
     Ingrid Moráles, Manuel Rodrı́guez · 2012 · Glia
182. Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study
     Vania Gelmetti, Alessandro Ferraris, Livia Brusa, Francesca Romano, Federica Lombardi, Chiara Barzaghi, Paolo Stanzione, Barbara Garavaglia, Bruno Dallapiccola, Enza Maria Valente · 2008 · Movement Disorders
183. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases
     Aleksandra Maruszak, Katarzyna Gawęda-Walerych, Ireneusz Sołtyszewski, And Zekanowski · 2006 · Acta Neurobiologiae Experimentalis
184. Differential Age‐Related Loss of Pigmented Locus Coeruleus Neurons in Suicides, Alcoholics, and Alcoholic Suicides
     Victoria Arango, Mark D. Underwood, Donna Pauler Ankerst · 1996 · Alcoholism Clinical and Experimental Research
185. Apomorphine lowers dopamine synthesis for up to 48 h
     Manuel Rodrı́guez, Rafael Castro · 1991 · Neuroreport
186. PLASMAPHERESIS FOR PARAQUAT POISONING
     Jacob R. Miller, E. Sanders, D. Webb · 1978 · The Lancet
187. Age-related alterations in the protein expression profile of C57BL/6J mouse pituitaries
     Gorji Marzban, Johannes Grillari, Eva Reisinger · 2002 · Experimental Gerontology
188. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat
     Tomás González‐Hernández, Pedro Barroso‐Chinea, Manuel Rodrı́guez · 2004 · Movement Disorders
189. [Histochemical study on the regressive degeneration of the senile brain, with special reference to the aging of the substantia nigra].
     S Hirai · 1968 · PubMed
190. An immunohistochemical observation of manganese superoxide dismutase in rat substantia nigra after occlusion of middle cerebral artery
     Xiaohong Liu, Hiroyuki Kato, Tsutomu Araki, Yasuto Itoyama, Kanefusa Kato, Kyuya Kogure · 1994 · Neuroscience Letters
191. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse
     Jing Liu, Yanyong Wang, Li Liu, Quandong Wang, Zhen-Yun Yuan, Zhongxia Zhang, Ping Gu, Mingwei Wang · 2008 · Neuroscience Letters
192. Is the loss of thalamostriatal neurons protective in parkinsonism?
     Sheila V. Kusnoor, E. Chris Muly, James I. Morgan, Ariel Y. Deutch · 2009 · Parkinsonism & Related Disorders
193. Effect of Gender on Main Clinical Chemistry Parameters in Aged Rats
     Refik Kayalı, Seval Aydın, Ufuk Çakatay · 2009 · Current Aging Science
194. Striatal Glutamate Degenerates Thalamic Neurons
     Ingrid Moráles, Catalina Yanos, Clara Rodriguez‐Sabate, Alberto Sánchez, Manuel Rodrı́guez · 2013 · Journal of Neuropathology & Experimental Neurology
195. Localization of Axonal Motor Molecules Machinery in Neurodegenerative Disorders
     Fulvio Florenzano · 2012 · International Journal of Molecular Sciences
196. Untitled work
     1999 · 10.1002/(sici)1097-4547(19990715)57:2